Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | IPM | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | 100 uM | |||||
| Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
| Quantitative Method |
LFQ
|
|||||
| Competitor Name | Abegg_cp(-)-10 | Competitor Info | ||||
| Competitor Concentration | 30 uM | |||||
| In Vivo Experiment Model | Model Type |
|
Cell lysate | |||
| Derived Tissue |
|
Cervix uteri | ||||
| Disease Model | Endocervical adenocarcinoma [ICD-11:2C77] | |||||
| Model Name | Human endocervical adenocarcinoma cell lysate (HeLa) | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Sites | Binding Ratio | |||
|---|---|---|---|---|---|---|
| LDTP13904 | Probable ATP-dependent RNA helicase DDX52 (DDX52) | C536 | 2.3 | |||
| LDTP09819 | Unconventional myosin-XVIIIa (MYO18A) | C1699 | 2.1 | |||
| LDTP04251 | Elongation factor Tu, mitochondrial (TUFM) | C130 | 2.0 | |||
Transporter and channel
| Target ID | Target Name | Binding Sites | Binding Ratio | |||
|---|---|---|---|---|---|---|
| LDTP00196 | Unconventional myosin-Ic (MYO1C) | C802 | 2.3 | |||
Transcription factor
| Target ID | Target Name | Binding Sites | Binding Ratio | |||
|---|---|---|---|---|---|---|
| LDTP08216 | Protein polybromo-1 (PBRM1) | C1163 | 2.2 | |||
Other
| Target ID | Target Name | Binding Sites | Binding Ratio | |||
|---|---|---|---|---|---|---|
| LDTP01252 | Cold shock domain-containing protein E1 (CSDE1) | C42 | 3.2 | |||
| LDTP02941 | Integrin beta-5 (ITGB5) | C211 | 2.1 | |||
| LDTP09969 | Lipoma-preferred partner (LPP) | C364 | 2.1 | |||
| LDTP16285 | Transducin beta-like protein 2 (TBL2) | C44 | 2.0 | |||